Active Ingredient History

  • Now
Asoprisnil is a synthetic, steroidal selective progesterone receptor modulator that was under development by Schering and TAP Pharmaceutical Products for the treatment of uterine fibroids. In 2005, phase III clinical trials were discontinued due to endometrial changes in patients.   Wikipedia

  • SMILES: COC[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c5ccc(\C=N\O)cc5)OC
  • Mol. Mass: 449.59
  • ALogP: 5.43
  • ChEMBL Molecule:
More Chemistry
asoprisnil | bay86-5294 | benzaldehyde, 4-((11beta, 17beta)-17-methoxy-17-(methoxymethyl)-3-oxoestra-4, 9-dien-11beta-yl)-, 1-oxime | j867 | j867 cpd


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue